Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 3/20 | 0.40 |
| ▸ | LMNA | P02545 | 1/20 | 0.40 |
| ▸ | THRB | P10828 | 1/20 | 0.38 |
| ▸ | GGPS1 | O95749 | 1/20 | 0.35 |
| ▸ | FDPS | P14324 | 1/20 | 0.35 |
| ▸ | ESR1 | P03372 | 2/20 | 0.32 |
| ▸ | ESR2 | Q92731 | 2/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.32 |
| ▸ | SLC22A1 | O15245 | 2/20 | 0.30 |
| ▸ | SLC22A2 | O15244 | 1/20 | 0.30 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Phosphine SCHEMBL2473317 | 0.97 | TSHR (0.38) | TSHRLMNATHRBGGPS1FDPS | |
| Ammonia Solution, Strong SCHEMBL6265351 | 0.97 | TSHR (0.38) | TSHRLMNATHRBGGPS1FDPS | |
| SCHEMBL28605752 | 0.94 | GGPS1 (0.42) | TSHRLMNATHRBGGPS1FDPS | |
| SCHEMBL29260490 | 0.87 | TSHR (0.35) | TSHRLMNATHRBGGPS1FDPS | |
| Phosphine SCHEMBL3859233 | 0.84 | TSHR (0.47) | TSHRTHRBGGPS1FDPS | |
| Ammonia Solution, Strong SCHEMBL7557119 | 0.84 | TSHR (0.47) | TSHRTHRBGGPS1FDPS | |
| Ammonia Solution, Strong SCHEMBL8956892 | 0.84 | TSHR (0.47) | TSHRTHRBGGPS1FDPS | |
| SCHEMBL29284796 | 0.82 | TSHR (0.32) | TSHRLMNATHRBGGPS1FDPS | |
| SCHEMBL5533667 | 0.79 | — | — | |
| SCHEMBL5523842 | 0.79 | TSHR (0.40) | TSHRLMNATHRBGGPS1FDPS |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-111398605-B | Glycosylated hemoglobin measurement composition | 龟甲万株式会社 | 2024-04-05 | — | — | CN | disclosed |
| CN-112105677-B | Resin composition, resin sheet, and laminate | 琳得科株式会社 | 2023-03-28 | — | — | CN | disclosed |
| US-20080261923-A1 | Alkene Mimics | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2008-10-23 | — | — | US | disclosed |
| US-20070015892-A1 | Method for producing polymer, polymer, composition for forming insulating film, method for producing insulating film, and insulating film | JSR CORPORATION (JP) | 2007-01-18 | — | — | US | disclosed |
| EP-1705206-A1 | METHOD FOR PRODUCING POLYMER, POLYMER, COMPOSITION FOR FORMING INSULATING FILM, METHOD FOR PRODUCING INSULATING FILM, AND INSULATING FILM | JSR Corporation (JP) | 2006-09-27 | — | — | EP | disclosed |
| WO-2006020417-A2 | ALKENE MIMICS | VIRGINIA TECH INTELLECTUAL PROPERTIES, INC. (US) | 2006-02-23 | — | — | WO | disclosed |
| EP-0710241-A1 | NOVEL SILYLATED BENZYLAMINE DERIVATIVES, SALTS THEREOF, METHODS OF MANUFACTURE AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | PIERRE FABRE MEDICAMENT (FR) | 1996-05-08 | — | — | EP | disclosed |
| WO-1995003313-A1 | NOVEL SILYLATED BENZYLAMINE DERIVATIVES, SALTS THEREOF, METHODS OF MANUFACTURE AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | PIERRE FABRE MEDICAMENT (FR) | 1995-02-02 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080261923-A1 | Alkene Mimics | PHOSPHO1, PARN, CHAMP1 | TSHR 3267/4885LMNA 1092/4885THRB 1211/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.